» Articles » PMID: 24857776

Synthesis and Antimalarial Activity of Metal Complexes of Cross-bridged Tetraazamacrocyclic Ligands

Abstract

Using transition metals such as manganese(II), iron(II), cobalt(II), nickel(II), copper(II), and zinc(II), several new metal complexes of cross-bridged tetraazamacrocyclic chelators namely, cyclen- and cyclam-analogs with benzyl groups, were synthesized and screened for in vitro antimalarial activity against chloroquine-resistant (W2) and chloroquine-sensitive (D6) strains of Plasmodium falciparum. The metal-free chelators tested showed little or no antimalarial activity. All the metal complexes of the dibenzyl cross-bridged cyclam ligand exhibited potent antimalarial activity. The Mn(2+) complex of this ligand was the most potent with IC50s of 0.127 and 0.157μM against the chloroquine-sensitive (D6) and chloroquine-resistant (W2) P. falciparum strains, respectively. In general, the dibenzyl hydrophobic ligands showed better anti-malarial activity compared to the activity of monobenzyl ligands, potentially because of their higher lipophilicity and thus better cell penetration ability. The higher antimalarial activity displayed by the manganese complex for the cyclam ligand in comparison to that of the cyclen, correlates with the larger pocket of cyclam compared to that of cyclen which produces a more stable complex with the Mn(2+). Few of the Cu(2+) and Fe(2+) complexes also showed improvement in activity but Ni(2+), Co(2+) and Zn(2+) complexes did not show any improvement in activity upon the metal-free ligands for anti-malarial development.

Citing Articles

New Cyclam-Based Fe(III) Complexes Coatings Targeting Biofilms.

Carvalho F, Gomes L, Teixeira-Santos R, Carapeto A, Mergulhao F, Almada S Molecules. 2025; 30(4).

PMID: 40005227 PMC: 11858526. DOI: 10.3390/molecules30040917.


Zinc from an Essential Element to an Antiparasitic Therapeutic Agent.

Navarro M, Daniel L, Colina-Vegas L, Visbal G ACS Omega. 2025; 10(3):2393-2414.

PMID: 39895759 PMC: 11780429. DOI: 10.1021/acsomega.4c07331.


Metal-Based Drug-DNA Interactions and Analytical Determination Methods.

Hangan A, Oprean L, Dican L, Procopciuc L, Sevastre B, Lucaciu R Molecules. 2024; 29(18).

PMID: 39339356 PMC: 11434005. DOI: 10.3390/molecules29184361.


Design, synthesis and antimycobacterial activity of imidazo[1,5-]quinolines and their zinc-complexes.

Marner M, Kulhanek N, Eichberg J, Hardes K, Dal Molin M, Rybniker J RSC Med Chem. 2024; 15(5):1746-1750.

PMID: 38784461 PMC: 11110795. DOI: 10.1039/d4md00086b.


A Cyclam Salt as an Antifungal Agent: Interference with spp. and Mechanisms of Virulence.

Cerqueira F, Medeiros R, Lopes I, Campos C, Ferraz M, Silva F Antibiotics (Basel). 2024; 13(3).

PMID: 38534657 PMC: 10967529. DOI: 10.3390/antibiotics13030222.


References
1.
Sanchez-Delgado R, Anzellotti A . Metal complexes as chemotherapeutic agents against tropical diseases: trypanosomiasis, malaria and leishmaniasis. Mini Rev Med Chem. 2004; 4(1):23-30. DOI: 10.2174/1389557043487493. View

2.
Khan A, Nicholson G, Greenman J, Madden L, McRobbie G, Pannecouque C . Binding optimization through coordination chemistry: CXCR4 chemokine receptor antagonists from ultrarigid metal complexes. J Am Chem Soc. 2009; 131(10):3416-7. PMC: 2680178. DOI: 10.1021/ja807921k. View

3.
Mutabingwa T . Artemisinin-based combination therapies (ACTs): best hope for malaria treatment but inaccessible to the needy!. Acta Trop. 2005; 95(3):305-15. DOI: 10.1016/j.actatropica.2005.06.009. View

4.
Maples D, Maples R, Hoffert W, Parsell T, van Asselt A, Silversides J . Synthesis and Characterization of the Chromium(III) complexes of Ethylene Cross-Bridged Cyclam and Cyclen Ligands. Inorganica Chim Acta. 2010; 362(6):2084-2088. PMC: 2746693. DOI: 10.1016/j.ica.2008.09.034. View

5.
Navarro M, Gabbiani C, Messori L, Gambino D . Metal-based drugs for malaria, trypanosomiasis and leishmaniasis: recent achievements and perspectives. Drug Discov Today. 2010; 15(23-24):1070-8. DOI: 10.1016/j.drudis.2010.10.005. View